Cryo treatment with partial kidney surgery for kidney tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at using a cold (cryoablation) treatment along with partial kidney surgery to treat certain kidney tumors. It may help shrink or control the tumor while preserving more healthy kidney tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 90 years old
- Your kidney tumor is 7 cm or smaller at its widest point
- More than half of the tumor sticks out from the kidney surface
- You have not had previous surgery on the same kidney
- Your cancer has not spread to distant organs (no M1 disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, gentle way to remove small kidney tumors using a robot. The goal is to avoid cutting off blood supply to the kidney and to leave healthy tissue behind. It may help you keep more kidney function while still treating the cancer.
This trial studies a robot-assisted surgery to remove part of the kidney while keeping the kidney cool to protect it. It may help patients who need this type of kidney surgery.
This trial compares two standard treatments for small kidney tumors: removing the tumor surgically (resection) or destroying it with heat or cold (ablation). The goal is to see which approach works better for tumors 3 cm or smaller.
This study tests a freezing technique, called cryoablation, to destroy small lung tumors. It may be an option if you cannot have surgery or other treatments, or if those treatments haven't worked.
This trial enrolls children whose doctors decide they need a freezing procedure called cryoablation. The study looks at how this treatment is used in infants and children, including situations where it may be difficult or not possible at some point.
This trial tests a treatment for early-stage lung cancer (stage I-IIA) that uses extreme cold to freeze and destroy the tumor, called cryoablation. Some patients will also receive an immunotherapy drug called serplulimab, which helps the immune system fight the cancer, to see if adding it improves outcomes.
Hear when a new Kidney Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.